Update on the distribution of Mansonella perstans in the southern part of Cameroon: Influence of ecological factors and mass drug administration with ivermectin

Parasites and Vectors

Volumn 9, Issue 1, 2016, Pages

  Wanji, Samuel ^a,b   Tayong, Dizzle Bita ^a,b   Layland, Laura E ^d,e   Datchoua Poutcheu, Fabrice R ^a,b   Ndongmo, Winston Patrick Chounna ^a,b   Kengne Ouafo, Jonas Arnaud ^a,b   Ritter, Manuel ^d,e   Amvongo Adjia, Nathalie ^b   Fombad, Fanny Fri ^a,b   Njeshi, Charity Nya ^b   Nkwescheu, Armand Seraphin ^c   Enyong, Peter A ^a,b   Hoerauf, Achim ^d,e  

^a UNIVERSITY OF BUEA   (Cameroon)

^b Research Foundation for Tropical Diseases and the Environment REFOTDE   (Cameroon)

^c MINISTRY OF PUBLIC HEALTH   (Cameroon)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e German Center for Infection Research (DZIF)   (Germany)

Author keywords

Bioecological zones; Cameroon; Distribution; Intensity; Ivermectin; Mansonella perstans; Mansonellosis; MDA; Microfilariae; Prevalence

Indexed keywords

IVERMECTIN; INSECTICIDE;

ADMINISTRATION OF DRUGS, FOOD AND CHEMICALS; ARTICLE; CAMEROON; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DECIDUOUS EQUATORIAL RAINFOREST; DENSE HUMID EQUATORIAL RAINFOREST; DOWN REGULATION; ENVIRONMENTAL FACTOR; FORESTED SAVANNA; GEOGRAPHIC DISTRIBUTION; GRASSLAND SAVANNA; HEALTH PROGRAM; MANSONELLA PERSTANS; MANSONELLIASIS; MASS DRUG ADMINISTRATION; MIXED INFECTION; MOSAIC FOREST SAVANNA; MYCOBACTERIUM; NONHUMAN; PLASMODIUM; PREVALENCE; RAIN FOREST; SAVANNA; SCREENING TEST; SPECIES DISTRIBUTION; SPECIES ENDEMICITY; TREND STUDY; ANIMAL; DRUG EFFECTS; ENDEMIC DISEASE; FEMALE; FOREST; GEOGRAPHY; GROWTH, DEVELOPMENT AND AGING; HUMAN; LONGITUDINAL STUDY; MALE; MANSONELLA; MICROFILARIA (NEMATODE LARVA); NEGLECTED DISEASE; POPULATION DENSITY;

ANIMALS; CAMEROON; CROSS-SECTIONAL STUDIES; ENDEMIC DISEASES; FEMALE; FORESTS; GEOGRAPHY; HUMANS; INSECTICIDES; IVERMECTIN; LONGITUDINAL STUDIES; MALE; MANSONELLA; MANSONELLIASIS; MICROFILARIAE; NEGLECTED DISEASES; POPULATION DENSITY; PREVALENCE; RAINFOREST;

EID: 84971553863     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/s13071-016-1595-1     Document Type: Article

References (29)

1. Simonsen PE, Onapa AW, Asio SM. Mansonella perstans filariasis in Africa. Acta Trop. 2011;120:109-20.
2. Agbolade OM, Akinboye DO, Olateju TM, Ayanbiyi OA, Kuloyo OO, Fenuga OO. Biting of anthropophilic Culicoides fulvithorax (Diptera: Ceratopogonidae), a vector of Mansonella perstans in Nigeria. Korean J Parasitol. 2006;44:67-72.
3. Wanji S, Tendongfor N, Esum M, Ndindeng S, Enyong P. Epidemiology of concomitant infections due to Loa loa, Mansonella perstans and Onchocerca volvulus in rainforest villages of Cameroon. Med Microbiol Immunol. 2003;192:15-21.
4. Bregani ER, Rovellini A, Mbaidoum N, Magnini MG. Comparison of different anthelminthic drug regimens against Mansonella perstans filariasis. Trans R Soc Trop Med Hyg. 2006;100:458-63.
5. Anosike JC, Dozie IN, Onwuliri CO, Nwoke BE, Onwuliri VA. Prevalence of Mansonella perstans infections among the nomadic Fulanis of northern Nigeria. Ann Agric Environ Med. 2005;12:35-8.
6. Useh MF, Ejezie GC. The status and consequences of Mansonella perstans infection in Calabar. Nigeria East Afr Med J. 1995;2:124-6.
7. Adalid-Peralta L, Fragoso G, Fleury A, Sciutto E. Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections. Int J Biol Sci. 2011;7:1412-26.
8. Ng TH, Britton GJ, Hill EV, Verhagen J, Burton BR, Wraith DC. Regulation of adaptive immunity; the role of interleukin-10. Front Immunol. 2013;4:129.
9. Groux H, Cottrez F. The complex role of interleukin-10 in autoimmunity. J Autoimmun. 2003;20:281-5.
10. Asio SM, Simonsen PE, Onapa AW. Analysis of the 24-h microfilarial periodicity of Mansonella perstans. Parasitol Res. 2009;104:945-8.
11. Van Hoegaerden M, Ivanoff B, Flocard F, Salle A, Chabaud B. The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella perstans. Ann Trop Med Parasitol. 1987;81(3):275-82.
12. Simonsen PE, Fischer PU, Hoerauf A, Weil GJ. The Filariases. Manson's Tropical Diseases, 23rd edition. Philadelphia: Elsevier Saunders; 2013.
13. Mommers EC, Dekker HS, Richard P, Garcia A, Chippaux JP. Prevalence of L. loa and M. perstans filariasis in southern Cameroon. Trop Geogr Med. 1995;47:2-5.
14. Rhett B. Types of rainforests. 2012. Rainforests.mongabay.com/0103.htm.
15. Centers for Disease Control and Prevention. Mansonellosis treatment and diagnosis information. 2013. http://www.cdc.gov/dpdx/mansonellosis/tx.html.
16. Sasa M. Microfilaria survey methods and analysis of survey data in filariasis control programmes. Bull WHO. 1967;37:629-65.
17. Ohirel TA, Ranachandran CP. Planches pour l'identification des filaires. Geneva: World Health Organization; 1997. p. 1-6.
18. Akue JP, Nkoghe D, Padilla C, Moussavou G, Moukana H, Mbou RA, Ollomo B, Leroy EM. Epidemiology of concomitant infection Due to Loa loa and Mansonella perstans in Gabon. PLoS Negl Trop Dis. 2011;5, e1329.
19. Noireau F, Carme B, Apembet JD, Gouteux JP. Loa loa and Mansonella persfans filariasis in the Chaillu Mountains, Congo: parasitological prevalence. Trans R Soc Trop Med Hyg. 1989;83:529-34.
20. Tatuene KJ, Fotsing RG, Nkoa T, Mbougua JB, Djeunga HC, Bopda J, Kamgno J. Epidemiology of Loa loa and Mansonella perstans filariasis in the Akonolinga Health District, Centre Region. Cameroon Health Sci Dis. 2014;15:1-5.
21. Asio SM, Simonsen PE, Onapa AW. Mansonella perstans filariasis in Uganda: patterns of microfilaraemia and clinical manifestations in two endemic communities. Trans R Soc Trop Med Hyg. 2009;103:266-73.
22. Kyelem D, Sanou S, Boatin B, Medlock J, Coulibaly S, Molyneux DH. Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications. Ann Trop Med Parasitol. 2003;97:827-38.
23. Kyelem D, Medlock J, Sanou S, Bonkoungou M, Boatin B, Molyneux DH. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia. Trop Med Int Health. 2005;10:1002-4.
24. Fischer P, Kilian AH, Bamuhiiga J, Kipp W, Büttner DW. Prevalence of Mansonella perstans in western Uganda and its detection using the QBC-fluorescence method. Appl Parasitol. 1996;37:32-7.
25. Schulz-Key H, Albrecht W, Heuschkel C, Soboslay PT, Banla M, Görgen H. Efficacy of ivermectin in the treatment of concomitant Mansonella perstans infections in onchocerciasis patients. Trans R Soc Trop Med Hyg. 1993;227-229.
26. Metenou S, Babu S, Nutman TB. Impact of filarial infections on coincident intracellular pathogens: Mycobacterium tuberculosis and Plasmodium falciparum. Curr Opin HIV AIDS. 2012;7(3):231-8.
27. Aw O, Simonsen PE, Baehr I, Pedersen EM. Rapid assessment of the geographical distribution of Mansonella perstans infections in Uganda by screening school children for microfilariae. Ann Trop Med Parasitol. 2005;99(4):383-93.
28. Wanji S, Kengne-Ouafo JS, Esum ME, Chounna PN, Adzemye BF, Eyong JE, Jato I, Datchoua-Poutcheu FR, Abong AR, Enyong P, Taylor DW. Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon. Parasite Vectors. 2015;8:667.
29. Kengne-Ouafo JA, Nji TM, Tantoh WF, Nyoh DN, Tendongfor N, Enyong PA, Newport MJ, Davey G, Wanji S. Perceptions of consent, permission structures and approaches to the community: a rapid ethical assessment performed in North West Cameroon. BMC Public Health. 2014;14:1026.